Invesco Ltd. Emergent Bio Solutions Inc. Transaction History

Invesco Ltd.

$557 Billion
Q2 2025

A detailed history of Invesco Ltd. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Invesco Ltd. holds 565,274 shares of EBS stock, worth $5.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

565,274

Previous 747,959 24.42%

Holding current value

$5.04 Million

Previous $3.64 Million 0.8%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$4.26 - $6.94 $778,238 - $1.27 Million	-182,685 Reduced 24.42%	565,274 $3.61 Million
Q1 2025 May 12, 2025	SELL	$4.66 - $11.66 $3.69 Million - $9.23 Million	-791,948 Reduced 51.43%	747,959 $3.64 Million
Q4 2024 Feb 13, 2025	BUY	$7.72 - $11.97 $4.93 Million - $7.65 Million	638,995 Added 70.93%	1,539,907 $14.7 Million
Q3 2024 Nov 12, 2024	BUY	$5.72 - $14.77 $22,548 - $58,223	3,942 Added 0.44%	900,912 $7.52 Million
Q2 2024 Aug 13, 2024	BUY	$1.86 - $6.98 $7,609 - $28,555	4,091 Added 0.46%	896,970 $6.12 Million
Q1 2024 May 14, 2024	BUY	$1.5 - $3.41 $901,504 - $2.05 Million	601,003 Added 205.91%	892,879 $2.26 Million
Q4 2023 Feb 12, 2024	SELL	$1.82 - $3.16 $20,218 - $35,104	-11,109 Reduced 3.67%	291,876 $700,000
Q3 2023 Nov 13, 2023	SELL	$3.17 - $7.91 $1.54 Million - $3.85 Million	-486,870 Reduced 61.64%	302,985 $1.03 Million
Q2 2023 Aug 11, 2023	SELL	$7.35 - $13.21 $539,666 - $969,931	-73,424 Reduced 8.51%	789,855 $5.81 Million
Q1 2023 May 12, 2023	SELL	$7.79 - $16.29 $9.84 Million - $20.6 Million	-1,263,340 Reduced 59.41%	863,279 $8.94 Million
Q4 2022 Feb 13, 2023	BUY	$11.0 - $21.45 $12.6 Million - $24.6 Million	1,145,544 Added 116.76%	2,126,619 $25.1 Million
Q3 2022 Nov 14, 2022	BUY	$20.09 - $35.8 $3.22 Million - $5.75 Million	160,476 Added 19.56%	981,075 $20.6 Million
Q2 2022 Aug 15, 2022	SELL	$27.42 - $43.63 $1.83 Million - $2.91 Million	-66,763 Reduced 7.52%	820,599 $25.5 Million
Q1 2022 May 16, 2022	SELL	$36.48 - $52.22 $3.75 Million - $5.37 Million	-102,900 Reduced 10.39%	887,362 $36.4 Million
Q4 2021 Feb 14, 2022	BUY	$33.11 - $55.01 $8.67 Million - $14.4 Million	261,955 Added 35.97%	990,262 $43 Million
Q3 2021 Nov 15, 2021	SELL	$50.07 - $66.05 $1.28 Million - $1.69 Million	-25,522 Reduced 3.39%	728,307 $36.5 Million
Q2 2021 Aug 17, 2021	SELL	$56.61 - $80.46 $16.6 Million - $23.6 Million	-292,962 Reduced 27.99%	753,829 $47.5 Million
Q1 2021 May 17, 2021	SELL	$86.23 - $125.19 $2.44 Million - $3.54 Million	-28,283 Reduced 2.63%	1,046,791 $97.3 Million
Q4 2020 Feb 16, 2021	BUY	$79.17 - $111.47 $32.9 Million - $46.3 Million	415,547 Added 63.01%	1,075,074 $96.3 Million
Q3 2020 Nov 16, 2020	SELL	$81.91 - $134.94 $11.7 Million - $19.2 Million	-142,510 Reduced 17.77%	659,527 $68.1 Million
Q2 2020 Aug 14, 2020	SELL	$54.33 - $89.52 $5.99 Million - $9.86 Million	-110,187 Reduced 12.08%	802,037 $63.4 Million
Q1 2020 May 15, 2020	BUY	$49.34 - $68.76 $15 Million - $20.9 Million	303,427 Added 49.84%	912,224 $52.8 Million
Q4 2019 Feb 14, 2020	SELL	$51.21 - $59.06 $9.55 Million - $11 Million	-186,464 Reduced 23.45%	608,797 $32.8 Million
Q3 2019 Nov 14, 2019	SELL	$40.6 - $57.2 $2.74 Million - $3.87 Million	-67,604 Reduced 7.83%	795,261 $41.6 Million
Q2 2019 Aug 14, 2019	BUY	$39.92 - $53.86 $3.5 Million - $4.73 Million	87,799 Added 11.33%	862,865 $41.7 Million
Q1 2019 May 15, 2019	SELL	$48.23 - $66.16 $5.91 Million - $8.11 Million	-122,522 Reduced 13.65%	775,066 $39.2 Million
Q4 2018 Feb 14, 2019	BUY	$55.63 - $73.24 $49.9 Million - $65.7 Million	897,588 New	897,588 $53.2 Million

Others Institutions Holding EBS

# of Institutions

187

Shares Held

39.4M

Call Options Held

277K

Put Options Held

151K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $444M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account